Lv5
1500 积分 2024-08-15 加入
Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria
8天前
已完结
Depth of organ response in AL amyloidosis is associated with improved survival: new proposed organ response criteria
10天前
已完结
PRGN-2012 gene therapy in adults with recurrent respiratory papillomatosis: a pivotal phase 1/2 clinical trial
16天前
已完结
The Real‐World Safety and Efficacy of Bispecific T‐Cell Engager Therapy in Systemic AL Amyloidosis
29天前
已完结
A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis
1个月前
已完结
Options for Rescue Treatment of Patients with AL Amyloidosis Exposed to Upfront Daratumumab
1个月前
已完结
Outcomes of venetoclax-based therapy in patients with t(11;14) light chain amyloidosis after failure of daratumumab-based therapy
1个月前
已完结
Outcomes of patients with light chain (AL) amyloidosis after failure of daratumumab‐based therapy
1个月前
已完结
Update on B‐cell maturation antigen‐directed therapies in AL amyloidosis
2个月前
已完结
Maintenance therapy promotes profound organ and haematologic response in light-chain amyloidosis patients not undergoing autologous stem cell transplantation
2个月前
已完结
皖公网安备34019202002308
